Rajabpour Mojtaba Vand, Seyyedsalehi Monireh Sadat, Nahvijou Azin, Nemati Saeed, Javanmard Shaghayegh Haghjooy, Manteghinejad Amirreza, Abdi Sepideh, Farazmand Borna, Pirnejad Habibollah, Sorkheh Arash Golpazir, Anasari Jamshid, Bahrami Masoud, Marzban Maryam, Ghoreishi Seyedeh Masoumeh, Nia Yahya Baharvand Iran, Bakhshi Fataneh, Ansari-Moghaddam Alireza, Binabaj Maryam Moradi, Nourmohammadi Hassan, Omranipour Ramesh, Abdollahi Alireza, Aghili Mahdi, Mohagheghi Mohammad Ali, Ghanbari-Motlagh Ali, Basu Partha, Boffetta Paolo, Zendehdel Kazem
Cancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
BMC Cancer. 2025 May 23;25(1):925. doi: 10.1186/s12885-025-14260-3.
Data on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.
A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.
In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.
The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.
低收入和中等收入国家乳腺癌患者护理质量指标的数据有限。我们对伊朗的这些指标进行了评估。
选取了欧洲乳腺外科协会（EUSOMA）2017年定义的总共21项乳腺癌管理护理质量指标。根据伊朗11个省份建立的临床乳腺癌登记处的数据对这些指标进行回顾性评估。
在对6293例患者进行的21项指标研究中，15项指标比EUSOMA的标准水平低5%以上。
所定义的指标值低于EUSOMA建议的标准。本研究结果为伊朗及其他低收入和中等收入国家改善乳腺癌治疗效果的干预措施提供了重要线索。
